Human papillomavirus detection in cervical intraepithelial neoplasia by the second-generation hybrid capture microplate test, comparing two different cervical specimen collection methods

Clinical and Diagnostic Virology

Volumn 10, Issue 1, 1998, Pages 49-56

  Nindl, Ingo ^a   Lörincz, Attila ^b   Mielzynska, Iwona ^b   Petry, Ulrich ^c   Baur, Siegfried ^d   Kirchmayr, Reinhard ^d   Michels, Wolfgang ^a   Schneider, Achim ^a  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^b Digene Corporation   (United States)

^c HANNOVER MEDICAL SCHOOL   (Germany)

^d UNIVERSITY OF MUNICH   (Germany)

Author keywords

Cervical intraepithelial neoplasia; Cervical specimen collection method; Human papillomavirus; Hybrid Capture II; Viral load

Indexed keywords

ADULT; AGED; ARTICLE; COLPOSCOPY; DNA HYBRIDIZATION; FEMALE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; PAPANICOLAOU TEST; PRIORITY JOURNAL; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CONIZATION; VIRUS DETECTION; VIRUS INFECTION; VIRUS LOAD; WART VIRUS;

ADULT; AGED; CERVICAL INTRAEPITHELIAL NEOPLASIA; CERVIX UTERI; COHORT STUDIES; FEMALE; HUMANS; MIDDLE AGED; NUCLEIC ACID HYBRIDIZATION; PAPILLOMAVIRIDAE; SPECIMEN HANDLING;

EID: 0344813700     PISSN: 09280197     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0928-0197(98)00015-4     Document Type: Article

References (25)

1. Bosch FX, Manos MM, Munoz N, Sherman M, Jansen AM, Peto J, Schiffman MH, Moreno V, Kurman R, Shah KV. International Biological Study on Cervical Cancer (IBSCC) Study Group. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. J Natl Cancer Inst 1995:87;796-802.
2. Cox J.T., Lörincz A.T., Schiffman M.H., Sherman M.E., Cullen A., Kurman R.J. Human papillomavirus testing by hybrid capture appears to be useful in triaging women with a cytologic diagnosis of atypical squamous cells of undetermined significance. Am J Obstet Gynecol. 172:1995;946-954.
3. Cuzick J., Szarewski A., Terry G., Ho L., Hanby A., Maddox P., Anderson M., Kocjan G., Steele S.J., Guillebaud J. Human papillomavirus testing in primary cervical screening. Lancet. 345:1995;1533-1536.
4. de Villiers EM. Human pathogenic papillomavirus types: an update. In: zur Hausen H, editor, Human pathogenic papillomavirus, Vol. 186, Curr Top Microbiol Immunol, Berlin:Springer-Verlag, 1994:1-12.
5. Dürst M., Bosch F.X., Glitz D., Schneider A., zur Hausen H. Inverse relationship between human papillomavirus (HPV) type 16 early gene expression and cell differentiation in nude mouse epithelial cysts and tumors induced by HPV-positive human cell lines. J Virol. 65:1991;796-804.
6. Farthing A., Masterson P., Mason W.P., Vousden K.H. Human papillomavirus detection by hybrid capture and its possible clinical use. J Clin Pathol. 47:1994;649-652.
7. Hatch K.D., Schneider A., Abdel Nour M.W. An evaluation of human papillomavirus testing for intermediate- and high risk types as triage before colposcopy. Am J Obstet Gynecol. 172:1995;1150-1157.
8. Herrington C.S., Evans M.F., Charnock F.M., Gray W., O'D McGee J. HPV testing in patients with low grade cervical cytological abnormalities: a follow up study. J Clin Pathol. 49:1996;493-496.
9. Ho G.Y.F., Burk R.D., Klein S., Kadish A.S., Chang C.J., Palan P., Basu J., Tachezy R., Lewis R., Romney S. Persistent genital human papillomavirus infection as a risk factor for persistent cervical dysplasia. J Natl Cancer Inst. 87:1995;1365-1371.
10. IARC working group. IARC monographs on the evaluation of carcinogenic risk to humans. Vol. 64, Human papillomaviruses, Lyon, International Agency for Research on Cancer, 1995.
11. Londesborough P., Ho L., Terry G., Cuzick J., Wheeler C., Singer A. Human papillomavirus genotype as a predictor of persistence and development of high-grade lesions in women with minor cervical abnormalities. Int J Cancer. 69:1996;364-368.
12. Lörincz A.T., Reid R., Jenson A.B., Greenberg M.D., Lancaster W., Kurman R.J. Human papillomavirus infection of the cervix: relative risk associations of 15 common anogenital types. Obstet Gynecol. 79:1992;328-337.
13. Lörincz A.T. Hybrid capture method for detection of human papillomavirus DNA in clinical specimens. Pap Report. 7:1996;1-5.
14. Nindl I., Greinke C., Zahm D.M., Stockfleth E., Hoyer H., Schneider A. Human papillomavirus distribution in cervical tissues of different morphology as determined by hybrid capture assay and PCR. Int J Gynecol Pathol. 16:1997;197-204.
15. Östör A.G. Natural history of cervical intraepithelial neoplasia: a critical review. Int J Gynecol Pathol. 12:1993;186-192.
16. Reid R., Greenberg M.D., Lörincz A., Jenson A.B., Laverty C.R., Husain M., Daoud Y., Zado B., White T., Cantor D. Should cervical cytologic testing be augmented by cervicography or human papillomavirus deoxyribonucleic acid detection? Am J Obstet Gynecol. 164:1991;1461-1471.
17. Remmink A.J., Walboomers J.M.M., Helmerhorst T.J.M., Voorhorst F.J., Rozendaal L., Risse E.K.J., Meijer C.J.L.M., Kenemans P. The presence of persistent high risk HPV genotypes in dysplastic cervical lesions is associated with progressive disease: natural history up to 36 months. Int J Cancer. 61:1995;306-311.
18. Schiffman M.H., Kiviat N.B., Burk R.D., Shah K.V., Daniel R.W., Lewis R., Kuypers J., Manos M.M., Scott D.R., Sherman M.E., Kurman R.J., Stoler M.H., Glass A.G., Rush B.B., Mielzynska I., Lörincz A.T. Accuracy and interlaboratory reliability of human papillomavirus DNA testing by hybrid capture. J Clin Microbiol. 33:1995;545-550.
19. Schneider A., Oltersdorf T., Schneider V., Gissmann L. Distribution pattern of human papilloma virus 16 genome in cervical neoplasia by molecular in situ hybridisation of tissue sections. Int J Cancer. 39:1987;717-721.
20. Schneider A., Meinhardt G., Kirchmayr R., Schneider V. Prevalence of human papillomavirus genomes in tissues from the lower genital tract as detected by molecular in situ hybridization. Int J Gynecol Pathol. 10:1991;1-14.
21. Schneider A., Zahm D.M., Kirchmayr R., Schneider V.L. Screening for cervical intraepithelial neoplasia grade 2/3: validity of cytologic study, cervicography, and human papillomavirus detection. Am J Obstet Gynecol. 174:1996;1534-1541.
22. Sonnenberg A. Bonferroni-Holm sequential test procedure. Z. Gastroenterol. 23:1985;703-704.
23. van Ranst M., Kaplan J.B., Burk R.D. Phylogenetic classification of human papillomaviruses: correlation with clinical manifestations. J Gen Virol. 73:1992;2653-2660.
24. Walboomers JMM, de Roda Husman AM, van den Brule AJC, Snijders PJF, Meijer CJLM. Detection of genital human papillomavirus infections: critical review of methods and prevalence studies in relation to cervical cancer. In: Stern PL, Stanly M, editors, Human Papillomaviruses and Cervical Cancer, New York:Oxford University Press, 1994:41-71.
25. Wright T.C., Sun X.W., Koulos J. Comparison of management algorithms for the evaluation of women with low-grade cytologic abnormalities. Obstet Gynecol. 85:1995;202-210.